Physician profile
Michael D Eppig
NPI 1073536611
$3,129.83
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,320 · 2020: $16.52 · 2021: $70.46 · 2022: $288 · 2023: $226 · 2024: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,284.74 | 2019 | |
| Novo Nordisk INC | $196.40 | 2021-2024 | Wegovy, Rybelsus |
| Xeris Pharmaceuticals, INC. | $70.72 | 2023-2024 | Keveyis, Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.34 | 2022-2023 | Xifaxan |
| Lilly USA, LLC | $53.75 | 2022-2024 | Zepbound, Jardiance |
| Abbvie INC. | $48.12 | 2022 | |
| Glaxosmithkline, LLC. | $47.86 | 2024 | Trelegy Ellipta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $42.67 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.84 | 2022 | |
| Abbott Laboratories | $39.66 | 2023-2024 | Freestyle Libre 3 |
| Zimmer Biomet Holdings, INC. | $33.66 | 2019-2020 | |
| Amgen INC. | $27.44 | 2022 | |
| Lucid Diagnostics INC. | $22.96 | 2024 | |
| Genentech USA, INC. | $20.82 | 2022 | |
| Merck Sharp & Dohme LLC | $20.73 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $20.10 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.00 | 2024 | Airsupra |
| Ibsa Pharma INC. | $19.65 | 2022 | |
| Smith+Nephew, INC. | $18.00 | 2019 | |
| Exact Sciences Corporation | $16.99 | 2023 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $15.23 | 2023 | Contrave, Nexlizet, Nexletol |
| Janssen Pharmaceuticals, INC | $15.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eppig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.